MSB 2.89% $1.25 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-854

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 54 Posts.
    lightbulb Created with Sketch. 3
    Do we know the make-up of the FDA who are making the decision on MSB?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.